CVS Health Raised Its 2026 Outlook 3 Times, but Not Its Dividend
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
CVS Health (NYSE:CVS | CVS Price Prediction) has paid $0.665 per share every quarter since the January 19, 2024 ex-dividend date. That makes 12 identical payments in a row. Meanwhile, CVS has raised its 2026 guidance three times. It now expects adjusted EPS of at least $8.20 and operating cash flow of at least $15.5 billion. The cash exists. Management has other plans for it first.
Aetna’s Recovery Now Shows Up in Earnings
CVS runs three businesses. Health Care Benefits is Aetna, the insurance company that takes in premiums and pays medical bills, and Health Services includes Caremark, which negotiates drug prices for employers and health plans. Pharmacy & Consumer Wellness is the drugstore on the corner.
Aetna decides the outcome. Its medical benefit ratio improved. The ratio, or the share of premiums spent on care, reached 91.3% from 92.8% in the third quarter. Segment-adjusted operating income rose to $912M vs $314M a year earlier. Adjusted EPS of $2.09 beat the $1.65 consensus, marking the sixth straight beat.
UnitedHealth Group (NYSE:UNH) is profiting from the same trend. Its medical care ratio fell to 88.4%, compared with 89.9%. It expects to pay about $8,000 million in dividends in 2026. It had also bought back $5.0 billion of stock through September.
Coverage Leaves Ample Room for a Raise
The $2.66 annual dividend is roughly 32% of guided adjusted EPS. Free cash flow (operating cash minus capital spending) for the first three quarters of 2026 was about $12.96 billion. That covered dividends roughly 5 times, compared with about 2.3 times for full-year 2025. At $85.65, the stock yields about 3.1%.
Debt Repair Is Finished, and Buybacks Come First
Total debt dropped from $79.95 billion at the end of 2025 to $75.30 billion on September 30, a reduction of about $4.65 billion. CFO Brian Newman said on the earnings call that the work is done:
“We have made significant progress strengthening our balance sheet and have achieved our leverage goal ahead of schedule. This improved position, combined with our strong cash flow, will enable us to resume our share repurchase program in the fourth quarter.”[1]
He also said the 2027 adjusted EPS floor of $8.65[1] mostly assumes buybacks “just the offset of dilution.”
Walgreens Boots Alliance shows what happens when that cash buffer goes away. Before it agreed to be taken private, Walgreens had $766 million in cash and posted negative free cash flow of $418 million in one quarter.
Breakup Plan Could Delay the Answer
CVS plans to split into two public companies, with completion expected in the first half of 2028[1]. CEO David Joyner described what each company will get:
“Each company is expected to have a solid investment-grade capital structure and strong free cash flow. This will enable tailored capital allocation more closely aligned with each company’s strategy and growth opportunities.”[1]
Management did not commit to a dividend increase on the call, and the transcript also gives no timeline for one.
Verdict and the Signal to Track
Financially, CVS is ready to raise its dividend. Strategically, buybacks and the split take priority. Buybacks come first, and the dividend policy after the split probably has not been set. In the most recent increase, the board declared the higher payment on December 5, 2023. Its January announcements came on January 6, 2026, and January 3, 2025. If the next announcements come in above $0.665, the freeze is over. If Aetna’s benefit ratio climbs back toward 92.8%, the case for a raise gets weaker.
Contact [email protected] for any questions or corrections.








